#obln

Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot

— Obalon Therapeutics (NASDAQ: OBLN) reported a net loss of $0.61 per share for the third quarter of 2019, vs. $2.14 per share expected

— Third-quarter net loss was $3.7 million, compared to a loss of $6.7 million a year earlier

— Revenue decreased to $0.3 million from $3.0 million for the third quarter of 2018, vs. $1.2 million expected

— Cost of revenue was $0.4 million, down…

New Pick OBLN. High Risk – Entry 1/2 – Stop 20% Time, 3:47pm, June.24, 2018

23,513,292 shares of Common Stock outstanding as of December 31, 2018.

Interwest Venture Management Co  is the largest institutional owner

Tamarack Advisers, LP reported adding it to their portfolio on 9/30/18

  Social media metrics are off the charts right now

  **********WE ARE NOT FINANCIAL ADVISERS. THIS IS A HIGH RISK TRADE.…

Analysts See Upward Turn for Obalon Therapeutics Inc (Nasdaq:OBLN), Ending At $2.66

Obalon Therapeutics Inc (Nasdaq:OBLN)

August 23rd, 2018

Amidst falling markets Obalon Therapeutics Inc closed Thursday up 52.00%, a $0.91 increase to close on $2.66. In addition to finishing higher, trading volumes were solid at 3,477% of normal which can indicate investors see opportunities. (more…)

Volatile Trading With A Spread Of 36%, Obalon Therapeutics Inc (Nasdaq:OBLN) Close At $1.66

Obalon Therapeutics Inc (Nasdaq:OBLN)

August 2nd, 2018

Obalon Therapeutics Inc fell $0.01 Thursday, a 0.60% decline, closing at $1.66. Obalon Therapeutics Inc swung 35.62% between low and high. As well as the drop in value, Obalon Therapeutics Inc hit a new 52 week low of $1.46, breaking the previous low of $1.62 from earlier this May. Be aware that the Altman Z-Score1 (An indicator of the…

(Nasdaq:OBLN) Obalon Therapeutics Inc Earnings Report Expected Tomorrow

Obalon Therapeutics Inc (Nasdaq:OBLN)

August 1st, 2018

Obalon Therapeutics Inc closed Monday up 0.60%, a $0.01 increase to close on $1.67. Obalon Therapeutics Inc is expected to release a new earnings report tomorrow. Obalon Therapeutics Inc bounced 8.48% between high and low. (more…)

Breaking The Old 52 Week Low, Obalon Therapeutics Inc (Nasdaq:OBLN) Close At $1.86

Obalon Therapeutics Inc (Nasdaq:OBLN)

July 20th, 2018

Amidst falling markets Obalon Therapeutics Inc fell $0.11 Thursday, down 5.58%, closing at $1.86. As well as the drop in value, Obalon Therapeutics Inc hit a new 52 week low of $1.85, breaking the previous low of $1.88 from earlier this month. In addition to the stock finishing lower, the trading volumes were only 0.00% of normal which could…

(Nasdaq:OBLN) Obalon Therapeutics Inc Lowers The 52 Week Low

Obalon Therapeutics Inc (Nasdaq:OBLN)

July 18th, 2018

Obalon Therapeutics Inc fell $0.04 Wednesday, a 1.99% decline, closing at $1.97. As well as the drop in value, Obalon Therapeutics Inc hit a new 52 week low of $1.88, breaking the previous low of $2.01 from earlier this month. Obalon Therapeutics Inc swung 11.70% between low and high. (more…)

Obalon Therapeutics Inc (Nasdaq:OBLN) Closed Today On 52 Week Low Note

Obalon Therapeutics Inc (Nasdaq:OBLN)

July 16th, 2018

Obalon Therapeutics Inc fell $0.19 Monday which equals a 8.64% decline, closing at $2.01. Sadly, in addition to dropping OBLN ended up closing the day at a new 52 week low.As well as the drop in value, Obalon Therapeutics Inc hit a new 52 week low of $2.01, breaking the previous low of $2.08 from earlier this month. In addition to the stock…